Cardiovascular

Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity in Europe, placing a significant burden on healthcare systems, productivity, and the sustainability of economies. In this context, medical technology solutions are not merely supportive — they act as a catalyst for the transition to more efficient, preventive, and patient-centered models of care.

The field of cardiovascular medical technologies covers the entire patient journey — from early diagnosis to treatment and long-term monitoring. Specifically:

• Diagnostic blood tests enable early detection of risk factors, such as hypercholesterolemia, and the stratification of patients with increased cardiovascular risk.
• Modern imaging systems enhance accuracy in identifying vessel stenosis and pathologies.
• Implantable devices, such as pacemakers and defibrillators, as well as transcatheter technologies, are transforming the management of severe heart diseases.
• Continuous monitoring and remote patient monitoring systems enable preventive intervention and reduce hospitalization needs.
• Minimally invasive techniques, such as transcatheter valve interventions and stents, improve clinical outcomes, reduce complications, and lower the overall cost of care.

The value of cardiovascular technologies is not limited to innovation itself. The real challenge lies in their integration into a coherent healthcare ecosystem that leverages data, digital tools, and new reimbursement approaches. Without this systemic approach, even the most advanced technologies remain underutilized.

The SEIV Cardiovascular Sector aims to highlight the strategic role of these technologies, contribute to policy dialogue, and support the creation of an environment that enables faster and more equitable patient access to innovative solutions — delivering measurable benefits for the healthcare system and society as a whole.